Watch: 13 people with Parkinson’s on the impact of exercise
Health & Fitness
Author: Saskia MairPublished: 21 May 2020
Prep: Cook: Serves:
“What are the benefits of exercise?” A new global video project sees people with Parkinson’s share how staying active has helped them manage their symptoms – and encourages others with the condition to join in
People with Parkinson’s around the world – from Wales to
Peru and Canada to New Zealand –share how exercise has impacted their life with
the condition in a new video project.
In ‘What are the benefits of exercise?’ and ‘What keeps you motivated?’, participants show their routines – from weightlifting and running, to cycling and boxing – discuss the challenges they’ve faced, and highlight the effects of regular exercise, which include improving balance and posture, and supporting mental health.
They also contribute fitness tips for those who struggle to form a workout habit. “Find what you enjoy and use that to keep yourself moving,” suggests John Reyes from the USA who was diagnosed with Parkinson’s aged 36, while Jonny Acheson from the UK, who was diagnosed aged 41, recommends setting “a goal or challenge – and if at first you don’t succeed, just keep trying”.
Video creator Christine Jeyachandran, who lives in Peru, was diagnosed with the condition aged 37 and took up gymnastics to help manage her symptoms. She says that the experience inspired her to organise the project.
that I’d go whether I felt like it or not. As I advanced and improved my range
of movement, it encouraged me to try harder things. I had to overcome apathy, doubts, fatigue and fear to get serious
about exercising – but the benefits have been worth the effort.”
Christine has also made a ‘Before and After’ video, demonstrating how her symptoms have improved since starting her exercise routine. But, she says, showcasing stories from people of different ages, with varying experiences, is essential to persuade others to keep fit.
“I didn’t want people to say: ‘I couldn’t do that – you are younger and less affected than me’. So, I asked if others had benefited from exercise, and the videos say it all. These stories communicate with people with Parkinson’s better than scientific studies.”
And, although many are confined to their homes during the
coronavirus pandemic, it’s still vital to keep moving.
“Society might be in lockdown, but Parkinson’s disease is
ongoing,” she says. “In these times, it is harder to keep self-motivated, and if
I don’t exercise my body stiffens up and dyskinesia increases.
“Being stuck in an apartment gets to me, but when I do my
abdominal workout I feel so much better.”
Exercise and Parkinson’s
Research indicates that exercise can be neuroprotective – meaning it can slow down the progression of Parkinson’s. It can also provide physiological benefits
Ask for professional medical advice to find activities that suit your fitness and mobility level
Include a mixture of stretching, strengthening, weight bearing and balance exercises, alongside aerobic activity
Make sure you warm up first, and don’t try to do too much too quickly
“Brain Surgery Live is a modern medical miracle the public deserved to see”
Exposure for such modern miracles is crucial, argues Justin Rossi
4 days ago
Study suggests why neurons die in Parkinson’s disease
Researchers at the University of Córdoba, Spain, have discovered how a certain protein may be linked to death of dopamine-producing neurons associated with Parkinson’s. Using animal models of the condition to conduct their study, the team focused on the protein DJ-1 – whose link to Parkinson’s has previously been established, though its exact function was uncertain. The researchers compared neurons in the brains of mice that possessed the gene expressing DJ-1 with those that did not. The findings revealed that dysfunction or absence of the gene expressing the DJ-1 protein could trigger the ‘cell cycle’ (the process by which cells divide), which should not occur under normal conditions. Because neurons lack the capacity to divide, this causes them die – leading to the onset of symptoms linked with Parkinson’s. It is hoped that uncovering these details about the relationship between DJ-1’s absence and Parkinson’s may lead to the development of…
Researchers have finally identified brain cells linked to Parkinson’s disease
For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…
Tiny DBS implant shows potential to advance Parkinson’s disease treatment
In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”